Laura D. Corden
University of Dundee
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Laura D. Corden.
American Journal of Human Genetics | 1999
Virginia P. Sybert; Julie S. Francis; Laura D. Corden; Lynne T. Smith; Molly Weaver; Stephens K; W.H. Irwin McLean
Bullous congenital ichthyosiform erythroderma (BCIE) is characterized by blistering and erythroderma in infancy and by erythroderma and ichthyosis thereafter. Epidermolytic hyperkeratosis is a hallmark feature of light and electron microscopy. Here we report on four individuals from two families with a unique clinical disorder with histological findings of epidermolytic hyperkeratosis. Manifesting erythema and superficial erosions at birth, which improved during the first few months of life, affected individuals later developed palmoplantar hyperkeratosis with patchy erythema and scale elsewhere on the body. Three affected individuals exhibit dramatic episodic flares of annular, polycyclic erythematous plaques with scale, which coalesce to involve most of the body surface. The flares last weeks to months. In the interim periods the skin may be normal, except for palmoplantar hyperkeratosis. Abnormal keratin-filament aggregates were observed in suprabasal keratinocytes from both probands, suggesting that the causative mutation might reside in keratin K1 or keratin K10. In one proband, sequencing of K1 revealed a heterozygous mutation, 1436T-->C, predicting a change of isoleucine to threonine in the highly conserved helix-termination motif. In the second family, a heterozygous mutation, 1435A-->T, was found in K1, predicting an isoleucine-to-phenylalanine substitution in the same codon. Both mutations were excluded in both a control population and all unaffected family members tested. These findings reveal that a clinical phenotype distinct from classic BCIE but with similar histology can result from K1 mutations and that mutations at this codon give rise to a clinically unique condition.
Human Mutation | 1998
Laura D. Corden; Jemima E. Mellerio; M J Gratian; Robin A.J. Eady; John I. Harper; Marc Lacour; Gareth Magee; E. Birgitte Lane; John A. McGrath; W.H. Irwin McLean
We have studied a consanguineous family containing two children with severe, generalized epidermolysis bullosa simplex (EBS). Electron microscopy of skin biopsies from the affected individuals showed that basal keratinocytes were devoid of tonofilament bundles, although some single intermediate filament were visible. Genetic linkage analysis with the microsatellite probe D12S96 excluded the type II keratin gene cluster in this family. However, homozygosity by descent was observed with the polymorphic probes KRT9, KRT10 Ava II, and D17S1787 in both affected children, consistent with a recessive defect in a type I keratin. Immunoreactivity to keratin K5 and K15 was normal, but monoclonal antibodies LL001 and RCK107 against K14 showed no staining, suggesting a deficiency of K14 in these individuals. MRNA extracted from biopsy material was amplified by RT‐PCR to obtain full‐length K14 cDNA. Direct automated sequencing identified a homozygous nonsense mutation, W305X. A Hinf I restriction enzyme site is created by this nucleotide transition, which was used to confirm the presence of the mutation in this kindred and exclude it from 100 normal chromosomes. This is the fourth kindred with severe recessive EBS for whom a mutation has been found in the K14 gene. In this instance, the premature termination codon is the farthest downstream of the reported cases, occurring in the helix 2 domain and so giving a much longer translation product. Nevertheless, the heterozygous carriers are unaffected by the disease and display no epidermal fragility. We postulate that translation of the potentially dominant‐negative truncated K14 might be down‐regulated due to instability of the mutant mRNA, as observed in previous cases with similar mutations. Hum Mutat 11:279–285, 1998.© 1998 Wiley‐Liss, Inc.
British Journal of Dermatology | 2001
Rebecca M. Porter; Laura D. Corden; Declan P. Lunny; F.J.D. Smith; E. B. Lane; W.H.I. McLean
Background Keratins are a multigene family of intermediate filament proteins that are differentially expressed in specific epithelial tissues. To date, no type II keratins specific for the inner root sheath of the human hair follicle have been identified.
PLOS ONE | 2013
Aileen Sandilands; Frances J.D. Smith; Declan P. Lunny; Linda E. Campbell; Kirsty M. Davidson; Stephanie F. MacCallum; Laura D. Corden; Lesley Christie; Stewart Fleming; E. Birgitte Lane; W.H. Irwin McLean
Keratin 7 (K7) is a Type II member of the keratin superfamily and despite its widespread expression in different types of simple and transitional epithelia, its functional role in vivo remains elusive, in part due to the lack of any appropriate mouse models or any human diseases that are associated with KRT7 gene mutations. Using conventional gene targeting in mouse embryonic stem cells, we report here the generation and characterisation of the first K7 knockout mouse. Loss of K7 led to increased proliferation of the bladder urothelium although this was not associated with hyperplasia. K18, a presumptive type I assembly partner for K7, showed reduced expression in the bladder whereas K20, a marker of the terminally differentiated superficial urothelial cells was transcriptionally up-regulated. No other epithelia were seen to be adversely affected by the loss of K7 and western blot and immunofluorescence microscopy analysis revealed that the expression of K8, K18, K19 and K20 were not altered in the absence of K7, with the exception of the kidney where there was reduced K18 expression.
Nature Genetics | 1997
Alan D. Irvine; Laura D. Corden; O Swensson; B. Swensson; Johnny Moore; D. G. Frazer; F.J.D. Smith; R. G. Knowlton; Enno Christophers; R. Rochels; Jouni Uitto; W.H.I. McLean
Journal of Investigative Dermatology | 1997
Frances J.D. Smith; Laura D. Corden; E.L. Rugg; Irene M. Leigh; Celia Moss; Michael J. Tidman; Daniel Hohl; Marcel Huber; Lia Kunkeler; Colin S. Munro; E. Birgitte Lane; W.H. Irwin McLean
Journal of Investigative Dermatology | 1996
Marcel F. Jonkman; Klaas Heeres; Hendri H. Pas; Marja J. A. van Luyn; Job D. Elema; Laura D. Corden; Frances J.D. Smith; W.H. Irwin McLean; F.C.S. Ramaekers; Margaret Burton; H Scheffer
Experimental Eye Research | 2000
Laura D. Corden; Ole Swensson; Beate Swensson; Frances J.D. Smith; Rainer Rochels; Jouni Uitto; W.H. Irwin McLean
Biochemical and Biophysical Research Communications | 2002
Frances J.D. Smith; Rebecca M. Porter; Laura D. Corden; Declan P. Lunny; E. Birgitte Lane; W.H. Irwin McLean
Investigative Ophthalmology & Visual Science | 2011
Tara Moore; Haihui Liao; Alan D. Irvine; Louise F. Porter; Bethany Gibson; Laura D. Corden; Carrie J. MacEwen; Kathryn H. Weed; Jonathan E. Moore; William Henry Irwin Mclean